CERo Historical Financial Ratios

CEROW Stock   0.01  0  13.27%   
CERo Therapeutics is presently reporting on over 67 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, Days Sales Outstanding of 0.0 or Invested Capital of 0.0 will help investors to properly organize and evaluate CERo Therapeutics financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About CERo Financial Ratios Analysis

CERo TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CERo Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CERo financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CERo Therapeutics history.

CERo Therapeutics Financial Ratios Chart

Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.

Ev To Operating Cash Flow

A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.

Net Debt To E B I T D A

A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).

Current Ratio

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.
Most ratios from CERo Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into CERo Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

CERo Therapeutics fundamentals Correlations

-0.12-1.0-1.00.37-0.731.0-1.0-0.97-1.00.790.4-0.20.390.14-0.960.40.41-0.990.39-1.0-0.380.95-0.27-0.120.08
-0.120.060.120.820.72-0.120.070.370.21-0.690.87-0.950.870.970.390.870.860.280.870.2-0.83-0.420.991.00.98
-1.00.061.0-0.420.69-1.01.00.950.99-0.76-0.450.26-0.45-0.20.94-0.45-0.460.97-0.450.990.43-0.930.210.06-0.14
-1.00.121.0-0.360.73-1.01.00.971.0-0.8-0.390.19-0.39-0.140.96-0.39-0.40.99-0.391.00.37-0.950.280.13-0.07
0.370.82-0.42-0.360.190.37-0.41-0.13-0.29-0.260.93-0.920.930.91-0.110.930.93-0.220.93-0.3-0.810.080.730.810.89
-0.730.720.690.730.19-0.730.70.870.79-0.940.3-0.480.30.520.880.30.290.820.30.78-0.36-0.890.810.720.57
1.0-0.12-1.0-1.00.37-0.73-1.0-0.97-1.00.790.4-0.20.390.14-0.960.40.41-0.990.39-1.0-0.380.95-0.27-0.120.08
-1.00.071.01.0-0.410.7-1.00.950.99-0.76-0.440.24-0.44-0.190.94-0.44-0.450.98-0.440.990.42-0.940.230.07-0.12
-0.970.370.950.97-0.130.87-0.970.950.99-0.92-0.15-0.06-0.140.121.0-0.15-0.161.0-0.140.980.14-1.00.510.370.18
-1.00.210.991.0-0.290.79-1.00.990.99-0.85-0.310.11-0.31-0.050.98-0.31-0.321.0-0.311.00.29-0.980.360.210.01
0.79-0.69-0.76-0.8-0.26-0.940.79-0.76-0.92-0.85-0.240.44-0.24-0.48-0.93-0.24-0.23-0.88-0.24-0.840.210.94-0.8-0.69-0.54
0.40.87-0.45-0.390.930.30.4-0.44-0.15-0.31-0.24-0.981.00.96-0.121.01.0-0.241.0-0.32-0.970.090.780.860.95
-0.2-0.950.260.19-0.92-0.48-0.20.24-0.060.110.44-0.98-0.98-1.0-0.09-0.98-0.980.03-0.980.110.940.11-0.89-0.95-0.99
0.390.87-0.45-0.390.930.30.39-0.44-0.14-0.31-0.241.0-0.980.97-0.121.01.0-0.241.0-0.32-0.970.090.780.860.95
0.140.97-0.2-0.140.910.520.14-0.190.12-0.05-0.480.96-1.00.970.140.960.960.020.97-0.06-0.92-0.170.910.971.0
-0.960.390.940.96-0.110.88-0.960.941.00.98-0.93-0.12-0.09-0.120.14-0.12-0.130.99-0.120.980.11-1.00.530.40.21
0.40.87-0.45-0.390.930.30.4-0.44-0.15-0.31-0.241.0-0.981.00.96-0.121.0-0.241.0-0.32-0.970.090.770.860.95
0.410.86-0.46-0.40.930.290.41-0.45-0.16-0.32-0.231.0-0.981.00.96-0.131.0-0.251.0-0.33-0.970.110.770.860.94
-0.990.280.970.99-0.220.82-0.990.981.01.0-0.88-0.240.03-0.240.020.99-0.24-0.25-0.241.00.23-0.990.430.280.09
0.390.87-0.45-0.390.930.30.39-0.44-0.14-0.31-0.241.0-0.981.00.97-0.121.01.0-0.24-0.32-0.970.090.780.860.95
-1.00.20.991.0-0.30.78-1.00.990.981.0-0.84-0.320.11-0.32-0.060.98-0.32-0.331.0-0.320.3-0.970.350.20.01
-0.38-0.830.430.37-0.81-0.36-0.380.420.140.290.21-0.970.94-0.97-0.920.11-0.97-0.970.23-0.970.3-0.09-0.74-0.83-0.91
0.95-0.42-0.93-0.950.08-0.890.95-0.94-1.0-0.980.940.090.110.09-0.17-1.00.090.11-0.990.09-0.97-0.09-0.56-0.42-0.23
-0.270.990.210.280.730.81-0.270.230.510.36-0.80.78-0.890.780.910.530.770.770.430.780.35-0.74-0.560.990.94
-0.121.00.060.130.810.72-0.120.070.370.21-0.690.86-0.950.860.970.40.860.860.280.860.2-0.83-0.420.990.98
0.080.98-0.14-0.070.890.570.08-0.120.180.01-0.540.95-0.990.951.00.210.950.940.090.950.01-0.91-0.230.940.98
Click cells to compare fundamentals

CERo Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CERo Stock Analysis

When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.